arrow
S

Sameer A. Parikh

Mayo Clinic
H指数:46
被引数:8,661

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

How Many Lines of Therapy Do Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Receive in Routine Clinical Practice in the United States? Real World Evidence from the Targeted Therapy Era

在美国常规临床实践中,慢性淋巴细胞白血病/小淋巴细胞淋巴瘤患者接受了多少线治疗?靶向治疗时代的真实世界证据

2026-10-140
OA
Hodgkin lymphoma transformation in patients with chemotherapy-naïve chronic lymphocytic leukemia

化疗初治慢性淋巴细胞白血病患者中霍奇金淋巴瘤的转化

2026-09-260
OAAI
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Mayo Clinic Systematic Management and Risk-Adapted Therapy for Lymphoid Malignancies (lySMART) Consensus Guidelines 2026

慢性淋巴细胞白血病/小淋巴细胞淋巴瘤:梅奥诊所淋巴瘤系统性管理与风险适应疗法(lySMART)2026年共识指南

2026-06-050
PRE
Chronic Lymphocytic Leukemia/ Small Lymphocytic Lymphoma, Version 2.2026 Featured Updates to the NCCN Guidelines

NCCN Guidelines® 要点:慢性淋巴细胞白血病/小淋巴细胞淋巴瘤,版本 2.2026

2026-03-013
PRE
Central nervous system involvement in patients with Richter transformation of chronic lymphocytic leukemia (CLL): the Mayo Clinic experience

慢性淋巴细胞白血病(CLL)患者中Richter转化的中枢神经系统受累:梅奥诊所的经验

2026-01-070
OAAI
CHIP amplifies the risk of lymphoid malignancies in individuals with monoclonal B-cell lymphocytosis (MBL)

CHIP在单克隆B细胞淋巴增生病(MBL)患者中增加了患淋巴系统恶性肿瘤的风险。

2025-11-060
OAAI
Genomic profiling reveals molecular heterogeneity in patients with Richter transformation (RT) and chronic lymphocytic leukemia (CLL)

基因组分析揭示了Richter transformation (RT)和chronic lymphocytic leukemia (CLL)患者中的分子异质性。

2025-11-010
OAAI
COVID-19 convalescent plasma for B-cell depleted patients: a systematic review and individual patient data meta-analysis

COVID-19康复期血浆用于B细胞耗竭患者:一项系统评价和单个患者数据Meta分析

2025-10-170
OAAI
State of the art biology, progression, and clinical management of monoclonal B-cell lymphocytosis (MBL): consensus report from the Intercepting Blood Cancers Workshop Committee

单克隆B细胞淋巴增多症(MBL)的最新生物学、进展和临床管理:Intercepting Blood Cancers Workshop Committee的共识报告

2025-08-290
OAAI
The role of imaging studies in predicting time to first treatment and overall survival in high-count monoclonal B-cell lymphocytosis

高计数单克隆B细胞淋巴细胞增多症中影像学研究在预测首次治疗时间及总生存期方面的作用

2025-07-150
PRE
Disease-specific U1 spliceosomal RNA mutations in mature B-cell neoplasms

特定疾病的U1剪接体RNA突变在成熟B细胞肿瘤中

Leukemia
IF13.4
2025-06-300
OAAI
Outcomes of patients with Richter transformation who received no prior chemoimmunotherapy for their CLL

未接受过既往化疗免疫疗法治疗的Richter转化CLL患者的结局

2025-02-201
OA
Genomic characterization of chronic lymphocytic leukemia in patients of African ancestry

非洲血统患者慢性淋巴细胞白血病的基因组特征

2025-02-061
OA
Incidence of Richter transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma in the targeted therapy era
LEUKEMIA
IF13.4
2024-12-100
PRE
Mosaic chromosomal alterations (mCAs) in individuals with monoclonal B-cell lymphocytosis (MBL)

单克隆b细胞淋巴细胞增多症 (MBL) 患者的镶嵌染色体改变 (mCAs)

2024-11-060
OAAI
Rewiring Cancer Drivers to Induce Apoptosis By Transcriptional Chemical Inducers of Proximity in Chronic Lymphocytic Leukemia

通过转录化学邻近诱导剂重编程癌症驱动基因以诱导慢性淋巴细胞白血病的凋亡

BLOOD
IF23.1
2024-11-050
PRE